CIK 0001746473 · Non-accelerated filer<br>Smaller reporting company
PLIANT THERAPEUTICS, INC.
Sign in to watch- Ticker
- PLRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 474272481
- Phone
- 650-481-6770
- Business address
- 331 OYSTER POINT BOULEVARD, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 90 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-04-17 | Coulie Bernard President and CEO | Grant or award · Stock Option (Right to Buy) | +256,300 | 256,300 | ||
| 2026-04-17 | Coulie Bernard President and CEO | Returned to the company · Stock Option (Right to Buy) | −325,000 | 0 | ||
| 2026-04-17 | Coulie Bernard President and CEO | Grant or award · Stock Option (Right to Buy) | +325,000 | 325,000 | ||
| 2026-04-17 | Cheung Lily Chief Human Resource Officer | Returned to the company · Stock Option (Right to Buy) | −123,000 | 0 | ||
| 2026-04-17 | Cheung Lily Chief Human Resource Officer | Grant or award · Stock Option (Right to Buy) | +123,000 | 123,000 | ||
| 2026-04-17 | Cheung Lily Chief Human Resource Officer | Returned to the company · Stock Option (Right to Buy) | −52,000 | 0 | ||
| 2026-04-17 | Cheung Lily Chief Human Resource Officer | Grant or award · Stock Option (Right to Buy) | +52,000 | 52,000 | ||
| 2026-04-17 | Cheung Lily Chief Human Resource Officer | Returned to the company · Stock Option (Right to Buy) | −51,750 | 0 | ||
| 2026-04-17 | Cheung Lily Chief Human Resource Officer | Grant or award · Stock Option (Right to Buy) | +51,750 | 51,750 | ||
| 2026-01-22 | Cummings Keith Lamont Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +400,000 | 400,000 | ||
| 2026-01-22 | Kuo Minnie Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +300,000 | 300,000 | ||
| 2026-01-22 | Cheung Lily Chief Human Resource Officer | Grant or award · Stock Option (Right to Buy) | +300,000 | 300,000 | ||
| 2026-01-22 | Coulie Bernard President and CEO | Grant or award · Stock Option (Right to Buy) | +1,230,000 | 1,230,000 | ||
| 2026-01-20 | Cummings Keith Lamont Chief Financial Officer | Sale 10b5-1 | −24,002 | $1.28 | $31K | 297,214 |
| 2026-01-20 | Cheung Lily Chief Human Resource Officer | Sale 10b5-1 | −7,534 | $1.28 | $10K | 44,847 |
| 2026-01-20 | Coulie Bernard President and CEO | Sale 10b5-1 | −89,375 | $1.28 | $114K | 505,601 |
| 2026-01-20 | Kuo Minnie Chief Operating Officer | Sale 10b5-1 | −6,917 | $1.28 | $9K | 37,806 |
| 2025-06-05 | Bruhn Suzanne Louise Director | Grant or award · Common Stock (Right to Buy) | +30,000 | 30,000 | ||
| 2025-06-05 | Knobil Katharine Director | Grant or award · Common Stock (Right to Buy) | +30,000 | 30,000 | ||
| 2025-06-05 | MCCOURT Thomas A Director | Grant or award · Common Stock (Right to Buy) | +30,000 | 30,000 |
Page 3 of 8 · 160 trades